Erratum: Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice (Scientific Reports (2012) 2 (498) DOI: 10.1038/srep00498);Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Takanashi, Seiji ^a   Hara, Kazuo ^a   Aoki, Kaoru ^a   Usui, Yuki ^b   Shimizu, Masayuki ^a   Haniu, Hisao ^a   Ogihara, Nobuhide ^a   Ishigaki, Norio ^a   Nakamura, Koichi ^a   Okamoto, Masanori ^a   Kobayashi, Shinsuke ^a   Kato, Hiroyuki ^a   Sano, Kenji ^c   Nishimura, Naoyuki ^d   Tsutsumi, Hideki ^e   MacHida, Kazuhiko ^e   Saito, Naoto ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

^d Nakashima Medical Co Ltd   (Japan)

^e CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CARBON; CARBON NANOTUBE; CARCINOGEN; PROTEIN P21;

ANIMAL; ARTICLE; CARCINOGEN TESTING; GENETICS; LUNG; MALE; METABOLISM; MOUSE; PATHOLOGY; SKIN; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; TRANSGENIC MOUSE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARBON; CARCINOGENICITY TESTS; CARCINOGENS; INJECTIONS, SUBCUTANEOUS; LUNG; MALE; MICE; MICE, TRANSGENIC; NANOTUBES, CARBON; PROTO-ONCOGENE PROTEINS P21(RAS); SKIN; SPLEEN; SURVIVAL ANALYSIS;

EID: 84863840150     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01688     Document Type: Erratum

References (54)

1. Oberlin, A., Endo, M. & Koyama, T. Filamentous growth of carbon through benzene decomposition. J. Sryst. Growth 32, 335-349 (1976).
2. Iijima, S. Helical microtubules of graphitic carbon. Nature 354, 56-58 (1991). (Pubitemid 21896780)
3. Qu, L., Dai, L., Stone, M., Xia, Z. & Wang, Z. L. Carbon nanotube arrays with strong shear binding-on and easy normal lifting-off. Science 322, 238-242 (2008).
4. Shannon, M. A. et al. Science and technology for water purification in the coming decades. Nature 452, 301-310 (2008). (Pubitemid 351430783)
5. Xiong, F., Liao, A. D., Estrada, D.& Pop, E. Low-power switching of phase-change materials with carbon nanotube electrodes. Science 332, 68-570 (2011)
6. Van Noorden, R. Chemistry: the trials of new carbon. Nature 469, 14-16 (2011).
7. Endo, M. et al. Vapor-grown carbon fibers (VGCFs) basic properties and their battery applications. Carbon 39, 1287-1297 (2001). (Pubitemid 32535945)
8. Kang, S. J. et al. High-performance electronics using dense, perfectly aligned arrays of single-walled carbon nanotubes. Nat. Nanotechnol. 2, 230-236 (2007). (Pubitemid 46739814)
9. Scrosati, B. Nanomaterials: paper powers battery breakthrough. Nat. Nanotechnol. 2, 598-599 (2007). (Pubitemid 47525200)
10. Pugno, N. M., Bosia, F. & Carpinteri, A. Multiscale stochastic simulations for tensile testing of nanotube-based macroscopic cables. Small 4, 1044-1052 (2008).
11. Byrne, M. T. & Gun'ko, Y. K. Recent advances in research on carbon nanotube-polymer composites. Adv. Mater. 22, 1672-1688 (2010).
12. Pagona, G. & Tagmatarchis, N. Carbon nanotubes: materials for medicinal chemistry and biotechnological applications. Curr. Med. Chem. 13, 1789-1798 (2006). (Pubitemid 43871756)
13. Saito, N. et al. Carbon nanotubes for biomaterials in contact with bone. Curr. Med. Chem. 15, 523-527 (2008). (Pubitemid 351472419)
14. Saito, N. et al. Carbon nanotubes: biomaterial applications. Chem. Soc. Rev. 38, 1897-1903 (2009).
15. Harrison, B. S. & Atala, A. Carbon nanotube applications for tissue engineering. Biomaterials 28, 344-353 (2007). (Pubitemid 44537381)
16. Dubin, R. A., Callegari, G., Kohn, J. & Neimark, A. Carbon nanotube fibers are compatible with Mammalian cells and neurons. IEEE Trans Nanobioscience 7. 11-14 (2008).
17. Usui, Y. et al. Carbon nanotubes with high bone-tissue compatibility and boneformation acceleration effects. Small 4, 240-246 (2008). (Pubitemid 351271157)
18. Lee, H. H., Sang Shin, U., Lee, J. H. & Kim, H.W. Biomedical nanocomposites of poly(lactic acid) and calcium phosphate hybridized with modified carbon nanotubes for hard tissue implants. J. Biomed. Mater. Res. B Appl. Biomater. 98B, 246-254 (2011).
19. Shi Kam, N. W., Jessop, T. C., Wender, P. A. & Dai, H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 126, 6850-6851 (2004). (Pubitemid 38855367)
20. Yang, F. et al. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. Eur. J. Cancer. 47, 1873-1882 (2011).
21. Muller, J. et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 207, 221-231 (2005). (Pubitemid 41207915)
22. Lam, C. W., James, J. T., McCluskey, R., Arepalli, S. & Hunter, R. L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 36, 189-217 (2006).
23. Carrero-Sanchez, J. C. Biocompatibility and toxicological studies of carbon nanotubes doped with nitrogen. Nano Lett. 6, 1609-1616 (2006). (Pubitemid 44327519)
24. Poland, C. A. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3, 423-428 (2008).
25. Ma-Hock, L. et al. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol. Sci. 112, 468-481 (2009).
26. Auffan, M. et al. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 4. 634-641 (2009).
27. Oyabu, T. et al. Biopersistence of inhaled MWCNT in rat lungs in a 4-week well-characterized exposure. Inhal. Toxicol. 23, 784-791 (2011).
28. Nagai, H. et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc. Natl. Acad. Sci. USA 108, E1330-1338 (2011).
29. Porter, D. W. et al.Mouse pulmonary dose-and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269, 136-147 (2010).
30. Kobayashi, N. et al. Biological response and morphological assessment of individually dispersed multi-wall carbon nanotubes in the lung after intratracheal instillation in rats. Toxicology 276, 143-153 (2010).
31. ISO 10993-1:2009 Biological evaluation of medical devices Part 1: Evaluation and testing.
32. van der Zande, M., Junker, R., Walboomers, X. F. & Jansen, J. A. Carbon nanotubes in animal models: a systematic review on toxic potential. Tissue Eng. Part B Rev. 17, 57-69 (2011).
33. Long, G. G.,Morton, D., Peters, T., Short, B. & Skydsgaard,M. Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation. Toxicol. Pathol. 38, 43-50 (2010).
34. Palazzi, X. & Kergozien-Framery, S. Use of rash2 transgenic mice for carcinogenesis testing of medical implants. Exp. Toxicol. Pathol. 61, 433-441 (2009).
35. Hara, K. et al. Evaluation of CNT toxicity in comparison to tattoo ink nanoparticles for use as a biomaterial. Mater. Today 14, 434-440 (2011).
36. Urano, K. et al. Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. J. Toxicol. Sci. 32, 367-375 (2007). (Pubitemid 350021956)
37. Firme, 3rd, C. P. & Bandaru, P. R. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine 6, 245-256 (2010).
38. Beg, S. et al. Advancement in carbon nanotubes: basics, biomedical applications and toxicity. J. Pharm. Pharmacol. 63, 141-163 (2011).
39. Shvedova,A. A. et al.Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol. Ther. 121, 192-204 (2009).
40. Yang, K. & Liu, Z. In vivo biodistribution, pharmacokinetics, and toxicology of carbon nanotubes. Curr. Drug Metab. (2012) Epub ahead of print
41. Wang, L. et al. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part. Fibre Toxicol. 7, 31 (2010).
42. Palomäki, J. et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 27, 6861-6870 (2011).
43. Patlolla, A. K., Berry, A.&Tchounwou, P. B. Study of hepatotoxicity and oxidative stress in male Swiss-Webster mice exposed to functionalized multi-walled carbon nanotubes. Mol. Cell Biochem. 358, 189-199 (2011).
44. Sanchez, V. C.,Weston, P., Yan, A., Hurt, R. H. & Kane, A. B. A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials. Part. Fibre Toxicol. 8, 17 (2011).
45. Teeguarden, J. G. et al. Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol. Sci. 120, 123-135 (2011).
46. Ando, K. et al. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res. 52, 978-982 (1992).
47. Boverhof, D. R. et al. Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci. 121, 207-233 (2011).
48. Urano, K., Tamaoki, N. & Nomura, T. Establishing a laboratory animal model from a transgenic animal: rasH2 mice as a model for carcinogenicity studies in regulatory science. Vet. Pathol. 49, 16-23 (2012).
49. Urano, K. et al. Use of IC tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice. J. Toxicol. Sci. 31, 407-418 (2006). (Pubitemid 46045153)
50. Palazzi, X. & Kergozien-Framery, S. Use of rasH2 transgenic mice for carcinogenesis testing of medical implants. Exp. Toxicol. Pathol. 61, 433-441 (2009).
51. Di Sotto, A., Chiaretti, M., Carru, G. A., Bellucci, S. & Mazzanti, G. Multi-walled carbon nanotubes: Lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol. Lett. 184, 192-197 (2009).
52. Thurnherr, T. et al. A comparison of acute and long-term effects of industrial multiwalled carbon nanotubes on human lung and immune cells in vitro. Toxicol. Lett. 200, 176-186 (2011).
53. Naya, M. et al. Evaluation of the genotoxic potential of single-wall carbon nanotubes by using a battery of in vitro and in vivo genotoxicity assays. Regul. Toxicol. Pharmaco. 61, 192-198 (2011).
54. Sargent, L. M., Reynolds, S. H. & Castranova, V. Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology 4, 396-408 (2010).